Paying users zone. Data is covered by .

  • Get to AbbVie Inc. for $19.99, or

  • get to whole website for at least 3 months from $49.99.

 

$19.99


Ratios (Summary)

AbbVie Inc., debt and solvency ratios

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Debt to equity
Debt to capital
Interest coverage

Source: Based on data from AbbVie Inc. Annual Reports

Ratio Description The company
Debt-to-equity ratio A solvency ratio calculated as total debt divided by total shareholders' equity. AbbVie Inc.'s debt-to-equity ratio improved from 2015 to 2016 and from 2016 to 2017.
Debt-to-capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders' equity. AbbVie Inc.'s debt-to-capital ratio improved from 2015 to 2016 and from 2016 to 2017.
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. AbbVie Inc.'s interest coverage ratio deteriorated from 2015 to 2016 and from 2016 to 2017.

Top


Debt to Equity

AbbVie Inc., debt to equity calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Short-term borrowings
Current portion of long-term debt and lease obligations
Long-term debt and lease obligations, excluding current portion
Total debt
Stockholders' equity
Ratio
Debt to equity1
Benchmarks
Debt to Equity, Competitors
Abbott Laboratories
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Debt to Equity, Sector
Pharmaceuticals & Biotechnology
Debt to Equity, Industry
Health Care

Source: Based on data from AbbVie Inc. Annual Reports

2017 Calculations

1 Debt to equity = Total debt ÷ Stockholders' equity
= ÷ =

Ratio Description The company
Debt-to-equity ratio A solvency ratio calculated as total debt divided by total shareholders' equity. AbbVie Inc.'s debt-to-equity ratio improved from 2015 to 2016 and from 2016 to 2017.

Top


Debt to Capital

AbbVie Inc., debt to capital calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Short-term borrowings
Current portion of long-term debt and lease obligations
Long-term debt and lease obligations, excluding current portion
Total debt
Stockholders' equity
Total capital
Ratio
Debt to capital1
Benchmarks
Debt to Capital, Competitors
Abbott Laboratories
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Debt to Capital, Sector
Pharmaceuticals & Biotechnology
Debt to Capital, Industry
Health Care

Source: Based on data from AbbVie Inc. Annual Reports

2017 Calculations

1 Debt to capital = Total debt ÷ Total capital
= ÷ =

Ratio Description The company
Debt-to-capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders' equity. AbbVie Inc.'s debt-to-capital ratio improved from 2015 to 2016 and from 2016 to 2017.

Top


Interest Coverage

AbbVie Inc., interest coverage calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net earnings
Add: Income tax expense
Add: Interest expense
Earnings before interest and tax (EBIT)
Ratio
Interest coverage1
Benchmarks
Interest Coverage, Competitors
Abbott Laboratories
Allergan PLC
Amgen Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Celgene Corp.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Interest Coverage, Sector
Pharmaceuticals & Biotechnology
Interest Coverage, Industry
Health Care

Source: Based on data from AbbVie Inc. Annual Reports

2017 Calculations

1 Interest coverage = EBIT ÷ Interest expense
= ÷ =

Ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. AbbVie Inc.'s interest coverage ratio deteriorated from 2015 to 2016 and from 2016 to 2017.

Top